A Diet Fortified with Anthocyanin-Rich Extract (RED) Reduces Ileal Inflammation in a Senescence-Prone Mice Model of Crohn's-Disease-like Ileitis
- PMID: 40298846
- PMCID: PMC12024068
- DOI: 10.3390/antiox14040473
A Diet Fortified with Anthocyanin-Rich Extract (RED) Reduces Ileal Inflammation in a Senescence-Prone Mice Model of Crohn's-Disease-like Ileitis
Abstract
SAMP mice develop progressive Crohn's disease (CD)-like ileitis without spontaneous colitis that worsens over time without chemical, genetic, or immunological manipulation. Even growing in an identical vivarium and fed with the same diet, SAMP mice reveal a distinct fecal microbiome, metabolome, and lipidome profile compared to AKR mice, their non-inflamed parental control strain. Differences are already present in 5-week-old mice, with a tendency to increase in 15-week-old mice. SAMP and AKR mice metabolome and lipidome profiles were substantially different, belonging to two clusters in line with the progression of intestinal disease. Similarly, the 16S analysis confirmed differences between 15-week-old AKR and SAMP mice. The protective role of dietary polyphenols has been documented in inflammatory bowel diseases (IBD); thus, we supplemented the chow diet with an anthocyanin-rich extract (RED) to evaluate disease reduction in SAMP mice and changes in fecal microbiota/metabolome. Our data reveal that 10-week supplementation with anthocyanin-rich extract ameliorated disease severity in SAMP mice despite limited fecal microbiota/metabolome differences.
Keywords: Crohn’s disease; adjuvant therapy; metabolome; microbiota; polyphenols.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Dulai P.S., Singh S., Jiang X., Peerani F., Narula N., Chaudrey K., Whitehead D., Hudesman D., Lukin D., Swaminath A., et al. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn’s Disease: Results From the US VICTORY Consortium. Am. J. Gastroenterol. 2016;111:1147–1155. doi: 10.1038/ajg.2016.236. - DOI - PubMed
Grants and funding
- PNRR- MAD-2022-12376791 "Rafforzamento e potenziamento della ricerca biomedica del SSN", Financed by European Nation - NextGenerationEU, CUP C53C22001140007/Italian Ministry of Helath
- 2022 PNRR Project "Changing the future of intestinal failure in intestinal chronic inflammation: towards innovative predictive factors and therapeutic targets."" 2022 PNRR project "ONFOODS"/National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3, Theme 10
- CNR project Nutrage - Call for tender No. 3138 of 16 December 2021, rectified by Decree n.3175 of 18 December 2021 of Italian Ministry of University and Research funded by the European Union - NextGenerationEU. Project code CN_00000033, Concession Decree/National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.4
- Project PIR01_00032 BIO OPEN LAB BOL "CUP" J37E19000050007, project CIR01_00032 - BOL "BIO Open Lab - Rafforzamento del capitale umano/Ministero dell'Università e della Ricerca (MIUR)
- PRP@CERIC CUP J97G22000400006/Pathogen Readiness Platform for CERIC ERIC upgrade
LinkOut - more resources
Full Text Sources
Research Materials
